Split Dosing of Darzalex Over Consecutive Days Approved by FDA for Multiple Myeloma Patients
The U.S. Food and Drug Administration has approved a…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
$75M Gift to Establish Center for Blood Cancers at NYU Langone Health Center
Owing to an anonymous $75 million gift, New…
Real-world Data Supports Use of Oral Triple Combination in Treating Advanced Multiple Myeloma, Study Finds
Real world data from multiple myeloma patients in Hungary…
Isatuximab Extends Time Without Cancer Progression in Phase 3 Trial of Multiple Myeloma
Adding isatuximab to a standard of care treatment…
Thalidomide at 100 mg Shows Benefits as Maintenance Therapy in Multiple Myeloma Patients in Trial
A maintenance treatment with thalidomide at 100 mg a day…
Donation Will Establish Center for Multiple Myeloma Research in UK
Thanks to a £10 million donation (about $13,000,000), Imperial…
